Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Antiphospholipid Syndrome Treatment Global Market Report 2024
... End-Users: Hospitals; Homecare; Specialty CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG Antiphospholipid Syndrome Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More
-
2024 Global Forecast for Autoimmune Disease Diagnosis Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Therapeutic Vaccines Market Size, Trends, Analysis, and Outlook By Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines, Others), By Technology (Allogeneic Vaccine, Autologous Vaccine), by Region, Country, Segment, and Companies, 2024-2030
... The global Therapeutic Vaccines market size is poised to register 13.11% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Therapeutic Vaccines ... Read More
-
Autoimmune Hemolytic Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Corticosteroids, Monoclonal Antibodies, Others), By Route of Administration (Oral, Injectable), By Therapy (First Line Therapy, Second Line Therapy, Third Line Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Pharmacy), By Disease (Cold Antibody Hemolytic Anemia, Warm Antibody Hemolytic Anemia), By Treatment (Surgery, Medication), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Pharmacy), By Disease (Cold Antibody Hemolytic Anemia, Warm Antibody Hemolytic Anemia), By Treatment (Surgery, Medication), by Region, Country, Segment, and Companies, 2024-2030 The global Autoimmune Hemolytic Anemia Therapeutics market ... Read More
-
mAb Biosimilars Market Size, Trends, Analysis, and Outlook By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End-User (Hospitals, Cancer Treatment centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global mAb Biosimilars market size is poised to register 8.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mAb ... Read More
-
Liver Disease Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), By Disease (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Liver Disease Treatment market size is poised to register 6.28% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Immunoassay Market Assessment, By Product [Reagents and Kits, Analyzers, Software and Services], By Technique [Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR, Other Techniques], By Specimen [Blood, Saliva, Urine, Others], By Application [Oncology, Cardiology, Therapeutic Drug Monitoring, Infectious Diseases, Endocrinology, Autoimmune Diseases, Others], By End-user [Hospitals, Clinical Laboratories, Pharmaceutical and Biotech Companies, Blood Banks, Others], By Region, Opportunities and Forecast, 2017-2031F
... Cardiology, Therapeutic Drug Monitoring, Infectious Diseases, Endocrinology, Autoimmune Diseases, Others], By End-user [Hospitals, Clinical Laboratories, Pharmaceutical and Biotech Companies, Blood Banks, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunoassay market is projected to witness ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Vitamin D Therapy Market Size, Trends, Analysis, and Outlook By Route of Administration (Oral, Parenteral), By Purchasing Patterns (Prescription, Over-The-Counter), By Application (Osteoporosis, Muscle Weakness, Autoimmune Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Vitamin D Therapy market size is poised to register 11.85% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vitamin D ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Biopharmaceuticals Contract Manufacturing market size is poised to register 5.82% growth from 2024 to 2030, presenting significant ... Read More
-
Systemic Lupus Erythematosus Market Size, Trends, Analysis, and Outlook By Drug Class (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, Biologics), By Route of Administration (Oral, Intravenous, Subcutaneous), by Region, Country, Segment, and Companies, 2024-2030
... Erythematosus market size is poised to register 7.07% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Systemic Lupus Erythematosus market across By ... Read More
-
Autologous Cell Therapy Market Size, Trends, Analysis, and Outlook By Therapy , Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, Others), By Source (Bone Marrow, Epidermis, Others), By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Autologous Cell Therapy market size is poised to register 18.41% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Immunoassay Market Size, Trends, Analysis, and Outlook By Product (Reagents & Kits, Analyzers Type, Analyzers Purchase Mode), By Technology (ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting, Others), By Specimen (Blood, Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories, Home Care Settings), by Region, Country, Segment, and Companies, 2024-2030
... Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology ... Read More
-
Implantable Drug Delivery Devices Market Size, Trends, Analysis, and Outlook By Product (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bioabsorbable Stents, Intraocular Implants, Infusion Pumps, Others), By Type (Biodegradable, Non-biodegradable), By Technology (Diffusion, Osmotic, Magnetic, Others), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Osmotic, Magnetic, Others), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Implantable Drug Delivery Devices market size is poised to register 8.37% growth from ... Read More
-
Biosimilar Monoclonal Antibodies Market Size, Trends, Analysis, and Outlook By Product (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab, Others), By Application (Oncology, Chronic & Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Biosimilar Monoclonal Antibodies market size is poised to register 20.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilar Monoclonal Antibodies market ... Read More
-
Small Molecule CDMO Market Size, Trends, Analysis, and Outlook By Product (Active Pharmaceutical Ingredients (API), Finished Drug Products), By Drug (Innovators, Generics), By Application (Oncology, Cardiovascular Disease, Central Nervous System (CNS) Conditions, Autoimmune/Inflammation, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Small Molecule CDMO market size is poised to register 6.17% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Stem Cell Therapy Market Size, Trends, Analysis, and Outlook By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source, Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord, Others), By Therapeutic Application, Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030
... Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Stem Cell Therapy market size is poised to register 16.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
Primary Care POC Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Glucose Testing, Hb1Ac Testing, Autoimmune Disease, Coagulation, Fertility, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030 The global Primary ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
Research Assistance
